
Medical Devices Reimbursement Market Report 2026
Global Outlook – By Payer (Public, Private), By Claims (Underpaid, Full), By Healthcare Setting (Hospitals, Outpatient Facilities, Other Healthcare Settings) - Market Size, Trends, And Global Forecast 2026-2035
Medical Devices Reimbursement Market Overview
• Medical Devices Reimbursement market size has reached to $648.71 billion in 2025 • Expected to grow to $998.61 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Minimally Invasive Surgery Drives Growth In The Medical Device Reimbursement Market • Market Trend: Advancing Medical Device Reimbursement Through Technological Innovation In Electronic Medical Records (EMRs) • North America was the largest region in 2025.What Is Covered Under Medical Devices Reimbursement Market?
Medical device reimbursement refers to the process by which insurance plans or payers pay healthcare providers for providing medically necessary devices to patients. This process involves determining the cost of the device, evaluating its effectiveness, and negotiating with payers to ensure that the device is covered by insurance. The main payers of medical device reimbursement are public and private. A public payer is a government-funded organization or entity responsible for financing and administering healthcare services for a specific population or country. The underpaid and full claims are requested by hospitals, outpatient facilities, and other healthcare settings.
What Is The Medical Devices Reimbursement Market Size and Share 2026?
The medical devices reimbursement market size has grown strongly in recent years. It will grow from $648.71 billion in 2025 to $706.49 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to growth in medical device adoption, expansion of public health insurance programs, rising healthcare expenditure, increased use of advanced medical devices, development of standardized billing codes.What Is The Medical Devices Reimbursement Market Growth Forecast?
The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $998.61 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increase in innovative and high-cost devices, growing payer scrutiny on cost effectiveness, expansion of outpatient care settings, rising demand for reimbursement transparency, evolution of reimbursement policy frameworks. Major trends in the forecast period include shift toward value-based reimbursement models, increasing complexity of reimbursement pathways, rising importance of clinical and economic evidence, growing focus on faster coverage decisions, expansion of reimbursement support services.Global Medical Devices Reimbursement Market Segmentation
1) By Payer: Public, Private 2) By Claims: Underpaid, Full 3) By Healthcare Setting: Hospitals, Outpatient Facilities, Other Healthcare Settings Subsegments: 1) By Public: Government Health Insurance Programs, National Health Services, Social Health Insurance 2) By Private: Private Health Insurance Plans, Employer-Sponsored Health Insurance, Out-of-Pocket ReimbursementWhat Is The Driver Of The Medical Devices Reimbursement Market?
The growing demand for minimally invasive surgeries is expected to propel the growth of the medical device reimbursement market going forward. Minimally invasive surgery (MIS) is a medical approach that utilizes specialized techniques and instruments to perform surgical procedures with the least disruption to the patient's body compared to traditional open surgery. The benefits of medical device reimbursement for minimally invasive surgery include increased patient access to advanced procedures and reduced healthcare costs through shorter hospital stays. For instance, in September 2023, according to the American Society of Plastic Surgeons (ASPS), a US-based plastic surgery specialty organization, there were 4,715,716 minimally invasive procedures performed using botulinum toxin type A (including Botox, Dysport, and Xeomin) in 2023, reflecting a 6% increase from the previous year. Dermal fillers also saw significant use, with 3,441,534 procedures performed, up 4% from 2022. Therefore, the growing demand for minimally invasive surgeries is driving the growth of the medical device reimbursement market.Key Players In The Global Medical Devices Reimbursement Market
Major companies operating in the medical devices reimbursement market are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Aetna Inc., Humana Inc., WellCare Health Plans Inc., Reliance Nippon Life Insurance Company Limited, Axa S.A., Assicurazioni Generali SpA, Allianz SE, Zurich Insurance Group Ltd., Aviva plc, Aegon Life Insurance Company, Munich Re Group, Kaiser Permanente, Centene Corporation, Bupa Group, Molina Healthcare, HCSC Health Care Service Corporation, Ping An Insurance Group, China Life Insurance Company, Oscar Health, Medibank Private Limited, Discovery Health LimitedGlobal Medical Devices Reimbursement Market Trends and Insights
Major companies operating in the medical device reimbursement market are focusing on developing technological advancements such as electronic medical records (EMR) to sustain their position in the market. Electronic medical records (EMRs) are digital versions of a patient's paper medical charts, which are used to support reimbursement claims, ensuring that devices are medically necessary and appropriately utilized. For instance, in April 2023, Wemex Corporation, a Japan-based IT solutions company, launched the medicom-HRf hybrid cloud, an integrated electronic medical record (EMR) system that uses cloud technology to support location-free operations for clinics. Hybrid cloud solutions such as Medicom-HRf can seamlessly integrate various data sources, such as patient records, medical billing, insurance claims, and regulatory information. This integration provides a comprehensive view of patient treatment and billing history, crucial for accurate reimbursement. Medical device companies can access up-to-date information on insurance coverage, reimbursement rates, and claim status.What Are Latest Mergers And Acquisitions In The Medical Devices Reimbursement Market?
In January 2025, Klick Health Inc., a Canada-based healthcare marketing and technology company, acquired Peregrine Market Access Inc. for an undisclosed amount. With this acquisition, Klick Health Inc. aims to enhance its market-access capabilities and strengthen client solutions by integrating Peregrine Market Access Inc.’s expertise in pricing, reimbursement, and health economics to improve market-entry strategies for pharmaceutical and biotech clients. Peregrine Market Access Inc. is a Canada-based healthcare consultancy that specializes in providing market-access strategy, health economics, and reimbursement solutions for life sciences companies.Regional Outlook
North America was the largest region in the medical devices reimbursement market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Medical Devices Reimbursement Market?
The medical devices reimbursement market includes revenues earned by entities by providing services such as coding and billing services, claims processing, coverage determination, benefit verification, coding and billing training, and pre-authorization and pre-certification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Medical Devices Reimbursement Market Report 2026?
The medical devices reimbursement market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical devices reimbursement industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Medical Devices Reimbursement Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $706.49 billion |
| Revenue Forecast In 2035 | $998.61 billion |
| Growth Rate | CAGR of 8.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Payer, Claims, Healthcare Setting |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Aetna Inc., Humana Inc., WellCare Health Plans Inc., Reliance Nippon Life Insurance Company Limited, Axa S.A., Assicurazioni Generali SpA, Allianz SE, Zurich Insurance Group Ltd., Aviva plc, Aegon Life Insurance Company, Munich Re Group, Kaiser Permanente, Centene Corporation, Bupa Group, Molina Healthcare, HCSC Health Care Service Corporation, Ping An Insurance Group, China Life Insurance Company, Oscar Health, Medibank Private Limited, Discovery Health Limited |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
